OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis
Yue Zhang, Lishan Lu, Rui Zheng
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Yue Zhang, Lishan Lu, Rui Zheng
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis
Xiaoyan Chang, Chenghao Wang, Linyou Zhang
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1703-1719
Open Access
Xiaoyan Chang, Chenghao Wang, Linyou Zhang
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1703-1719
Open Access
Mapping the landscape and exploring trends in macrophage-related research within non-small cell lung cancer: a comprehensive bibliometric analysis
Yinxue Zhou, Tingyu Wu, Jiangxing Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Yinxue Zhou, Tingyu Wu, Jiangxing Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Comparative efficacy of six programmed cell death Protein-1 inhibitors as first-line treatment for advanced non-small cell lung cancer: a multicenter retrospective cohort study
Siyuan Chen, Tao Li, Wenyu Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Siyuan Chen, Tao Li, Wenyu Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Non-small cell lung cancer and metabolism research from 2013 to 2023: a visual analysis and bibliometric study
Jin Yang, Wei Yang, Jie Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Jin Yang, Wei Yang, Jie Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Role of ICIs-Based Therapies and Bevacizumab for Advanced Wild-Type Non-Squamous NSCLC in the First-Line Setting: A Bayesian Network Analysis
Yang Song, Lingling Zhang, Wenwen Xu, et al.
(2023)
Closed Access
Yang Song, Lingling Zhang, Wenwen Xu, et al.
(2023)
Closed Access
